Ustekinumab Maintained Clinically Meaningful Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease: Results From the IM-UNITI Long-Term Extension

被引：0
|
作者：
Sands, Bruce E. [1 ]
Han, Chenglong [2 ]
Gasink, Christopher [3 ]
Bin, Zou [4 ]
Stephen, Targan [5 ]
Sandborn, William J. [6 ]
Feagan, Brian G. [7 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Janssen Global Serv LLC, Malvern, PA USA
[3] Janssen Sci Affairs LLC, Horsham, PA USA
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[6] Univ Calif San Diego, La Jolla, CA 92093 USA
[7] Robarts Clin Trials, London, ON, Canada
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
690
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [31] Cost Reduction Associated With Improvement in Work Productivity Loss From Ustekinumab Treatment by Disease Severity States in Crohn's Disease Patients: Results From the IM-UNITI Clinical Trial
    Teeple, Amanda
    Muser, Erik
    Naessens, Dominik
    Lueza, Beranger
    Kamal, Zahra
    Colonier, Astrid Foix
    Carlucci, Claudia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S233 - S233
  • [32] Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease
    Forss, Anders
    Clements, Mark
    Myrelid, Par
    Strid, Hans
    Soderman, Charlotte
    Wagner, Agnieszka
    Andersson, David
    Hjelm, Fredrik
    Olen, Ola
    Halfvarson, Jonas
    Ludvigsson, Jonas F.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (01) : 65 - 76
  • [33] Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease
    Anders Forss
    Mark Clements
    Pär Myrelid
    Hans Strid
    Charlotte Söderman
    Agnieszka Wagner
    David Andersson
    Fredrik Hjelm
    Ola Olén
    Jonas Halfvarson
    Jonas F. Ludvigsson
    Digestive Diseases and Sciences, 2023, 68 : 65 - 76
  • [34] Pharmacokinetics and Exposure-Response Relationships of Ustekinumab during IV Induction and SC Maintenance Treatment of Patients with Crohn's Disease with Ustekinumab: Results from the UNITI-1, UNITI-2, and IM-UNITI Studies
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Gasink, Christopher
    Szapary, Philippe
    Johanns, Jewel
    Gao, Long-Long
    Davis, Hugh M.
    Hanauer, Stephen B.
    Feagan, Brian G.
    Sandborn, William
    GASTROENTEROLOGY, 2016, 150 (04) : S408 - S408
  • [35] Ustekinumab improves disease specific health-related quality of life in patients with moderate to severe psoriasis: Results with the dermatology life quality index
    Lebwohl, M.
    Papp, K.
    Schenkel, B.
    Eisenberg, D.
    Yeilding, N.
    Guzzo, C.
    Wang, Y.
    Li, S.
    Krueger, G. G.
    VALUE IN HEALTH, 2008, 11 (03) : A293 - A293
  • [36] Normalization of long-term quality of life in Crohn's disease patients receiving ustekinumab
    Marques-Cami, Miquel
    Robles Alonso, Virginia
    Borruel, Natalia
    Herrera de Guise, Claudia
    Mayorga, Luis
    Casellas, Francesc
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2021, 113 (05) : 313 - 317
  • [37] Clinically Meaningful Improvement in Health-Related Quality of Life in a Randomized Controlled Trial of Certolizumab Pegol Maintenance Therapy for Crohn's Disease
    Feagan, Brian G.
    Coteur, Geoffroy
    Tan, Seng
    Keininger, Dorothy L.
    Schreiber, Stefan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (08): : 1976 - 1983
  • [38] Ustekinumab Improves Health-Related Quality of Life in Korean and Taiwanese Patients With Moderate to Severe Psoriasis: Results from the PEARL Trial
    Tsai, Tsen-Fang
    Song, Michael
    Shen, Yaung-Kaung
    Schenkel, Brad
    Choe, Yong-Beom
    Kim, Nack-In
    Lee, Joo-Heung
    Lee, Ju-Hee
    Song, Hae-Jun
    Youn, Jai-Il
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (08) : 943 - 949
  • [39] Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial
    Lebwohl, M.
    Papp, K.
    Han, C.
    Schenkel, B.
    Yeilding, N.
    Wang, Y.
    Krueger, G. G.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (01) : 137 - 146
  • [40] CLINICAL AND ENDOSCOPIC OUTCOMES WITH USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE LONG-TERM EXTENSION PERIOD OF THE STARDUST TRIAL
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    D'Haens, Geert R.
    Panes, Julian
    Dignass, Axel
    Magro, Fernando
    Nazar, Maciej
    Le Bars, Manuela
    Lahaye, Marjolein
    Ni, Lioudmila
    Bravata, Ivana
    Lavie, Frederic
    Daperno, Marco
    Lukas, Milan
    Armuzzi, Alessandro
    Lowenberg, Mark
    Gaya, Daniel R.
    Danese, Silvio
    GASTROENTEROLOGY, 2022, 162 (07) : S801 - S801
12345